Stratistics MRC에 따르면, 세계의 킬레이트화 셀레늄 시장은 2025년에 8억 6,000만 달러를 차지하고, 예측 기간 동안 CAGR 7.3%를 나타내 2032년에는 14억 1,000만 달러에 이를 것으로 예상됩니다.
킬레이트화 셀레늄은 생체이용률과 흡수를 향상시키기 위해 아미노산 및 펩타이드와 같은 유기 분자에 결합된 셀레늄의 형태입니다. 이것은 항산화 활성, 면역계 기능 및 일반적인 건강 를 촉진하기 위해 농업, 영양 보충제 및 동물 영양에서 널리 사용됩니다.
국제사료산업연맹(IFIF)에 따르면 전 세계적으로 연간 10억톤 이상의 배합사료가 생산되고 있습니다.
동물 영양에서 수요 증가
동물 영양학에서 킬레이트화 셀레늄 수요 증가는 가축의 건강과 생산성을 높이는데 중요한 역할을 하는 것이 배경에 있습니다. 또한 부족증을 예방하기 위해 사료에 대한 셀레늄 보급을 의무화하는 엄격한 규제가 채용을 더욱 뒷받침하고 있습니다.
엄격한 규정 준수
FDA 및 EFSA와 같은 기관은 과다 복용을 방지하기 위해 셀레늄 농도를 제한하고 있으며 제조업체는 복잡한 승인 프로세스를 통과해야합니다. 게다가 안전 가이드라인이 빈번하게 갱신되기 때문에 계속적인 재제조가 필요해, 경영상의 과제가 되고 있습니다.이러한 요인은 접근성을 제한해, 진입 장벽을 증대시킴으로써, 총체로서 시장의 성장을 억제하고 있습니다.
인간용 영양 보조 식품으로 확대
항산화 작용이 인정된 셀레늄은 산화 스트레스에 대항하여 갑상선 기능과 면역 기능을 지원합니다. 엔 라벨 보충제의 동향은 셀레노 메티오닌과 같은 제제의 기술 혁신을 추진하고 있습니다.
잠재적 독성 문제
그 장점에도 불구하고 셀레늄의 과다 복용은 장기와 신경계에 손상을주는 셀레노시스와 같은 독성 위험을 초래합니다. 경우 리콜이나 법적 책임, 풍평 피해로 이어질 수 있습니다. 또한 원료 조달의 일관성이없는 품질 관리는 안전 위험을 악화시킵니다.
COVID-19 팬데믹은 세계 공급망을 혼란시켜 킬레이트화 셀레늄 시장에서 원료 부족과 생산 지연을 일으켰습니다. 반대로, 건강 의식 증가가 면역력을 높이는 보충 수요를 밀어 올리고 손실을 부분적으로 상쇄했습니다.
예측 기간 동안 글리신 부문이 최대가 될 전망
글리신 부문은 뛰어난 생체 이용률과 안정성으로 동물사료 및 의약품에 이상적이므로 예측 기간 동안 최대 시장 점유율을 차지할 것으로 예상됩니다. 또한 식물의 산화 스트레스를 완화하는 글리신의 역할은 농업 용도에서의 사용을 확대하고 있습니다.
예측 기간 동안 액체 부문이 가장 높은 CAGR이 예상됩니다.
예측 기간 동안 사료 혼합물, 비료 및 영양 보충제에 통합하기 쉽기 때문에 액체 분야가 가장 높은 성장률을 보일 것으로 예상됩니다. 금류 및 낙농 산업에서 액체 보충제 수요 증가는 캡슐화 기술의 진보와 함께 성장을 더욱 촉진합니다.
예측 기간 동안 북미는 엄격한 동물 영양 규제, 첨단 농업 관행 및 영양 보충제에 대한 소비자의 높은 의식으로 최대 시장 점유율을 차지할 것으로 예상됩니다. 이 지역에서는 축산업이 확립되어 고기의 품질이 중시되어 셀레늄 강화 사료 수요가 높아지고 있습니다. 또한 강력한 연구 개발 능력과 아처 다니엘스 미들랜드와 카길과 같은 주요 기업의 존재가 시장의 우위를 높이고 있습니다. 식품과 사료의 미량 영양소 강화를 추진하는 정부의 이니셔티브이 북미의 주도적 지위를 더욱 견고하게 하고 있습니다.
예측기간 동안 가축생산 확대, 식육 소비 증가, 건강지향 증가로 아시아태평양이 가장 높은 CAGR을 나타낼 것으로 예측됩니다. 중국과 인도와 같은 국가들은 셀레늄 결핍에 대처하기 위해 현대 농업 기술과 영양 보충제에 투자하고 있습니다. 농업 생산성을 지원하는 정부의 정책과 도시화에 의한 가공 식품에 대한 수요가 더욱 채용을 가속화하고 있습니다. 게다가 신흥 경제국의 낮은 생산 비용과 미개발 잠재력은 이 지역을 고성장 시장으로 자리매김해 킬레이트화 셀레늄 용도에 대한 세계 투자를 유치하고 있습니다.
According to Stratistics MRC, the Global Chelated Selenium Market is accounted for $0.86 billion in 2025 and is expected to reach $1.41 billion by 2032 growing at a CAGR of 7.3% during the forecast period. Chelated selenium is a form of selenium bound to organic molecules, such as amino acids or peptides, to enhance bioavailability and absorption. It is extensively utilized in agriculture, nutritional supplements, and animal nutrition to promote antioxidant activity, immune system function, and general health. Compared to inorganic selenium sources, chelation increases the stability and efficacy of selenium, allowing the body to use it more effectively.
According to the International Feed Industry Federation (IFIF), over 1 billion tons of compound animal feed are produced annually worldwide.
Rising demand in animal nutrition
The increasing demand for chelated selenium in animal nutrition is driven by its critical role in enhancing livestock health and productivity. As a vital micronutrient, selenium improves immune function, fertility, and growth rates in animals, aligning with the growing focus on high-quality meat and dairy products. Additionally, stringent regulations mandating selenium supplementation in animal feed to prevent deficiencies further propel adoption. The rise in intensive farming practices and consumer demand for ethically sourced animal products also contribute to market growth.
Stringent regulatory compliance
Agencies like the FDA and EFSA enforce limits on selenium concentrations to prevent overexposure, requiring manufacturers to navigate complex approval processes. Compliance with regional standards increases production costs and delays product launches, particularly for small-scale players. Moreover, frequent updates to safety guidelines necessitate continuous reformulation, creating operational challenges. These factors collectively restrain market growth by limiting accessibility and increasing barriers to entry.
Expansion in human nutritional supplements
Recognized for its antioxidant properties, selenium combats oxidative stress and supports thyroid and immune functions. Rising prevalence of chronic diseases and aging populations amplify demand for selenium-enriched products. Furthermore, the trend toward personalized nutrition and clean-label supplements drives innovation in formulations like selenomethionine. Expansion into emerging markets, coupled with increasing health awareness, positions human nutrition as a lucrative growth avenue for market players.
Potential toxicity issues
Despite its benefits, excessive selenium intake poses toxicity risks, including selenosis, which can damage organs and nervous systems. Such concerns heighten regulatory scrutiny and consumer skepticism, particularly in unregulated markets. Incidents of over-supplementation in livestock or human products could lead to recalls, legal liabilities, and reputational damage. Additionally, inconsistent quality control in raw material sourcing exacerbates safety risks. These factors threaten market stability, necessitating rigorous quality assurance and consumer education to mitigate adverse impacts.
The Covid-19 pandemic disrupted global supply chains causing raw material shortages and production delays in the chelated selenium market. Lockdowns reduced demand from the livestock sector due to operational halts, while economic uncertainties slowed R&D investments. Conversely, heightened health awareness boosted demand for immune-boosting supplements, partially offsetting losses. Post-pandemic recovery in agriculture and nutraceuticals, coupled with stabilized supply chains, has driven gradual market resurgence.
The glycine segment is expected to be the largest during the forecast period
The glycine segment is expected to account for the largest market share during the forecast period due to its superior bioavailability and stability, making it ideal for animal feed and pharmaceuticals. Its cost-effectiveness and compatibility with diverse formulations enhance adoption in livestock and aquaculture industries. Additionally, glycine's role in reducing oxidative stress in plants amplifies its use in agricultural applications. The segment's established supply chain and proven efficacy in preventing selenium deficiencies solidify its leading position, particularly in regions with intensive farming practices.
The liquid segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the liquid segment is predicted to witness the highest growth rate attributed to its ease of integration in feed mixes, fertilizers, and nutraceuticals. Liquid chelated selenium offers precise dosing and faster absorption, appealing to modern farming and precision agriculture. Rising demand for liquid supplements in poultry and dairy industries, coupled with advancements in encapsulation technologies, further drives growth. Additionally, expanding applications in hydroponics and foliar sprays in horticulture bolster its adoption, positioning this segment for robust expansion.
During the forecast period, the North America region is expected to hold the largest market share due to stringent animal nutrition regulations, advanced agricultural practices, and high consumer awareness of dietary supplements. The region's well-established livestock industry and emphasis on meat quality drive demand for selenium-enriched feed. Moreover, strong R&D capabilities and the presence of key players like Archer Daniels Midland and Cargill enhance market dominance. Government initiatives promoting micronutrient fortification in food and feed further solidify North America's leading position.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to expanding livestock production, rising meat consumption, and increasing health consciousness. Countries like China and India are investing in modern farming techniques and nutritional supplements to address selenium deficiencies. Government policies supporting agricultural productivity and urbanization-driven demand for processed foods further accelerate adoption. Additionally, low production costs and untapped potential in emerging economies position the region as a high-growth market, attracting global investments in chelated selenium applications.
Key players in the market
Some of the key players in Chelated Selenium Market include BASF SE, DSM-Firmenich, Cargill, Incorporated, Archer Daniels Midland Company (ADM), Alltech, Zinpro Corporation, Novus International, Inc., Kemin Industries, Inc., Nutreco, Phibro Animal Health Corporation, Lallemand Animal Nutrition, DLG Group, Vitatrace Nutrition, Balchem Corporation, Orffa International B.V., Biochem (EW Group), Virbac SA and Mercer Milling Company.
In September 2024, HarvestPlus and Cargill are excited to announce the NutriHarvest project, a transformative 36-month initiative. This $3 million multi-year project, supported by Cargill and executed by HarvestPlus, is dedicated to increasing access to nutritious food while impacting more than 119,000 farmers across India, Kenya, Tanzania, and Guatemala, and delivering over 17 million nutritious meals.
In August 2024, Fonterra is set to expand its Studholme site in the South Island to create a hub for high value proteins. Fonterra's proteins have enhanced functionality and are designed to perform well in premium product applications such as medical and high-protein sports nutrition. Fonterra CEO Miles Hurrell says the investment of around $75 million is part of the Co-op's strategy to grow value through its world-leading Ingredients business by partnering with customers who value Fonterra's unique offering.